CVS, Cigna and Lina Khan
CVS, UnitedHealth, Cigna say FTC should take Lina Khan and two commissioners off drug middlemen case
The companies argue the commissioners have "a lengthy track record of making public statements that indicate serious bias" against pharmacy benefit managers.
CVS, UnitedHealth, Cigna Ask FTC's Khan to Disqualify Herself From Insulin Case
NEW YORK (Reuters) -CVS Health, UnitedHealth Group and Cigna have asked U.S. Federal Trade Commission chair Lina Khan and commissioners Rebecca Kelly Slaughter and Alvaro Bedoya to disqualify themselves from an FTC lawsuit that has accused the companies of unlawfully inflating insulin prices.
CVS, Cigna Seek to Disqualify FTC Officials in Insulin Case Over Alleged Bias
The healthcare company said Chair Lina Khan, Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro Bedoya through public statements show they have prejudged the matter at hand.
CVS, Cigna, UnitedHealth press for FTC Chair Khan to be removed from PBM lawsuit
Cigna, UnitedHealth and CVS Caremark are calling Federal Trade Commission (FTC) Chair Lina Khan and two other commissioners to either recuse themselves, or be removed from the agency’s lawsuit
CVS, UnitedHealth seek FTC recusal over bias in insulin case
The FTC has accused units of CVS, Cigna and UnitedHealth of unfair trade practices in how they managed insulin prescriptions.
Cigna seeks to disqualify FTC Chair Lina Khan from insulin case because of alleged bias
Cigna said that Khan, along with Commissioners Rebecca Kelly Slaughter and Alvaro Bedoya, have made repeated and incorrect prejudgments that show bias against pharmacy-benefit managers.
Healthcare Firms Call FTC’s Khan Biased. They Want Her Off the Insulin Case.
The agency has filed an administrative complaint accusing pharmacy benefit managers of artificially inflating the price of insulin.
CVS, UnitedHealth Request FTC Chair Recusal Amid Ongoing Pharmacy Benefit Managers Lawsuit
The FTC has filed a formal complaint accusing CVS, Cigna, and UnitedHealth of engaging in anti-competitive practices that ...
Seeking Alpha10d
CVS, Cigna PBMs targeted as lawmakers criticize new "anti-competitive" move
Wyden and Brown pointed to CVS (CVS) and Cigna’s (CI) manufacturing subsidiaries, Cordavis and Quallent Pharmaceuticals. Established to produce biosimilars against AbbVie’s (ABBV) Humira in ...
The Motley Fool17d
Are CVS Health, Cigna, and UnitedHealth Group Stocks Bad News Buys With the FTC's PBM Crackdown?
CVS Caremark said in a statement that it's drugmakers who are increasing the prices of drugs rather than PBMs. Cigna Chief Legal Officer Andrea Nelson said in a statement that the FTC's lawsuit is ...
New York Post21d
UnitedHealth, CVS Caremark, Express Scripts sued by FTC over skyrocketing insulin prices
The case accuses UnitedHealth Group’s Optum unit, CVS Health’s CVS Caremark and Cigna’s Express Scripts of unfairly excluding lower cost insulin products from lists of drugs covered by insurers.
Yahoo Finance1d
The Cigna Group (CI)
The lawsuit targets pharmaceutical companies such as Eli Lilly And Co (NYSE:LLY) and PBMs, including Cigna Corp's (NYSE:CI) Express Scripts and CVS Health Inc's (NYSE:CVS) CVS Pharmacy ...
Benzinga.com21d
UnitedHealth Vs. CVS Vs. Cigna: Which Health Stock Will Beat The FTC's Regulatory Heat?
FTC’s lawsuit against PBMs puts UnitedHealth, CVS, and Cigna stocks in focus for investors seeking stability. Cigna could see more price movement than UNH and CVS, thanks to its focused ...